Last reviewed · How we verify
2ccPA
At a glance
| Generic name | 2ccPA |
|---|---|
| Also known as | 2-carba-cyclic phosphatidic acid |
| Sponsor | Orient Europharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis (PHASE1, PHASE2)
- 2ccPA Study in Patients With Symptomatic Knee Osteoarthritis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2ccPA CI brief — competitive landscape report
- 2ccPA updates RSS · CI watch RSS
- Orient Europharma Co., Ltd. portfolio CI